Dr. Heinemann on Using Depth of Response in Pretreated Patients With CRC
У вашего броузера проблема в совместимости с HTML5
Volker Heinemann, MD, PhD, director of the Comprehensive Cancer Center at Ludwig Maximilian University of Munich, discusses using depth of response as an appropriate endpoint in studies examining patients with metastatic colorectal cancer (mCRC).